Understanding the pathophysiology of NOMID arthropathy for drug discovery by iPSCs technology

by Nakagawa, K, Okuno, Y, Nishikomori, R, Yokoyama, K, Tanaka, T, Kawai, T, Yasumi, T, Umeda, K, Nakayama, N, Toguchida, J, Hagiwara, M, Heike, T
Published 2015

Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients

by Doi, T, Takiuchi, H, Ohtsu, A, Fuse, N, Goto, M, Yoshida, M, Dote, N, Kuze, Y, Jinno, F, Fujimoto, M, Takubo, T, Nakayama, N, Tsutsumi, R
Published 2012

Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas

by Rahman, M T, Nakayama, K, Rahman, M, Katagiri, H, Katagiri, A, Ishibashi, T, Ishikawa, M, Iida, K, Nakayama, N, Otsuki, Y, Nakayama, S, Miyazaki, K
Published 2012

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer

by Koizumi, W, Yamaguchi, K, Hosaka, H, Takinishi, Y, Nakayama, N, Hara, T, Muro, K, Baba, H, Sasaki, Y, Nishina, T, Fuse, N, Esaki, T, Takagi, M, Gotoh, M, Sasaki, T
Published 2013

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer

by Koizumi, W, Yamaguchi, K, Hosaka, H, Takinishi, Y, Nakayama, N, Hara, T, Muro, K, Baba, H, Sasaki, Y, Nishina, T, Fuse, N, Esaki, T, Takagi, M, Gotoh, M, Sasaki, T
Published 2014